博雅生物发预减，预计2025年度归母净利润1.05亿元至1.37亿元，同比下降65.62%至73.55%

Core Viewpoint - Boya Bio (300294.SZ) forecasts a significant decline in net profit for the fiscal year 2025, projecting a net profit attributable to shareholders of between 105 million yuan and 137 million yuan, representing a year-on-year decrease of 65.62% to 73.55% [1] Financial Performance - The company anticipates a net loss of between 7.5 million yuan and 15 million yuan after excluding non-recurring gains and losses [1]